ESSA Pharma Stock Forecast, Price & News

ESSA Pharma (NASDAQ:EPIX) Frequently Asked Questions

Is ESSA Pharma a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ESSA Pharma in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ESSA Pharma stock.
View analyst ratings for ESSA Pharma or view top-rated stocks.

How has ESSA Pharma's stock price been impacted by COVID-19?

ESSA Pharma's stock was trading at $4.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EPIX stock has increased by 186.5% and is now trading at $11.66.
View which stocks have been most impacted by COVID-19.

Are investors shorting ESSA Pharma?

ESSA Pharma saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 937,100 shares, a decline of 25.0% from the October 31st total of 1,250,000 shares. Based on an average daily volume of 296,400 shares, the short-interest ratio is presently 3.2 days. Currently, 5.6% of the company's stock are short sold.
View ESSA Pharma's Short Interest.

When is ESSA Pharma's next earnings date?

ESSA Pharma is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for ESSA Pharma.

How were ESSA Pharma's earnings last quarter?

ESSA Pharma Inc. (NASDAQ:EPIX) announced its earnings results on Thursday, November, 18th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.03.
View ESSA Pharma's earnings history.

What price target have analysts set for EPIX?

4 equities research analysts have issued 12 month price targets for ESSA Pharma's stock. Their forecasts range from $22.00 to $50.00. On average, they expect ESSA Pharma's share price to reach $34.67 in the next twelve months. This suggests a possible upside of 197.3% from the stock's current price.
View analysts' price targets for ESSA Pharma or view top-rated stocks among Wall Street analysts.

Who are ESSA Pharma's key executives?

ESSA Pharma's management team includes the following people:

• Dr. David Ross Parkinson, Pres, CEO & Director (Age 71, Pay $788.6k)
• Mr. Peter A. Virsik M.B.A., M.S., Exec. VP & COO (Age 50, Pay $615.59k)
• Dr. Alessandra Cesano M.D., Ph.D., Chief Medical Officer
• Mr. David S. Wood C.M.A., CPA, M.B.A., MBA, CPA, CMA, Chief Financial Officer (Age 64)
• Chandtip Chandhasin, Exec.
• Erica Osbourne, Exec.
• Erin Rudsinski, Exec.
• Leah Dimascio, Exec.
• Loleta Harris, Exec.
• Neil Thapar, Exec.

Who are some of ESSA Pharma's key competitors?

Some companies that are related to ESSA Pharma include Taro Pharmaceutical Industries (TARO), Nektar Therapeutics (NKTR), Nuvation Bio (NUVB), Trillium Therapeutics (TRIL), Agios Pharmaceuticals (AGIO), Global Blood Therapeutics (GBT), Cassava Sciences (SAVA), Ironwood Pharmaceuticals (IRWD), Atai Life Sciences (ATAI), Avid Bioservices (CDMO), Turning Point Therapeutics (TPTX), Erasca (ERAS), Kadmon (KDMN), Travere Therapeutics (TVTX) and Enanta Pharmaceuticals (ENTA).
View all of EPIX's competitors.

What other stocks do shareholders of ESSA Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ESSA Pharma investors own include RedHill Biopharma (RDHL), Aurinia Pharmaceuticals (AUPH), Lipocine (LPCN), Trevena (TRVN), Allena Pharmaceuticals (ALNA), Protalix BioTherapeutics (PLX), Agile Therapeutics (AGRX), Biopharmx (BPMX), Corbus Pharmaceuticals (CRBP) and Heat Biologics (HTBX).

What is ESSA Pharma's stock symbol?

ESSA Pharma trades on the NASDAQ under the ticker symbol "EPIX."

Who are ESSA Pharma's major shareholders?

ESSA Pharma's stock is owned by many different retail and institutional investors. Top institutional investors include Bellevue Group AG (11.45%), Janus Henderson Group PLC (7.91%), BVF Inc. IL (6.48%), RTW Investments LP (6.00%), Citadel Advisors LLC (1.56%) and BioImpact Capital LLC (1.55%). Company insiders that own ESSA Pharma stock include Franklin M Berger and Growth N V Biotech.
View institutional ownership trends for ESSA Pharma.

Which institutional investors are selling ESSA Pharma stock?

EPIX stock was sold by a variety of institutional investors in the last quarter, including RTW Investments LP, Morgan Stanley, Sphera Funds Management LTD., Ensign Peak Advisors Inc, Schonfeld Strategic Advisors LLC, UBS Group AG, Citadel Advisors LLC, and Advisor Group Holdings Inc..
View insider buying and selling activity for ESSA Pharma or view top insider-selling stocks.

Which institutional investors are buying ESSA Pharma stock?

EPIX stock was acquired by a variety of institutional investors in the last quarter, including Bellevue Group AG, Janus Henderson Group PLC, BioImpact Capital LLC, Two Sigma Advisers LP, Two Sigma Investments LP, BVF Inc. IL, Rhenman & Partners Asset Management AB, and Millennium Management LLC. Company insiders that have bought ESSA Pharma stock in the last two years include Franklin M Berger, and Growth N V Biotech.
View insider buying and selling activity for ESSA Pharma or or view top insider-buying stocks.

How do I buy shares of ESSA Pharma?

Shares of EPIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ESSA Pharma's stock price today?

One share of EPIX stock can currently be purchased for approximately $11.66.

How much money does ESSA Pharma make?

ESSA Pharma has a market capitalization of $512.81 million. The company earns $-36.81 million in net income (profit) each year or ($0.97) on an earnings per share basis.

How many employees does ESSA Pharma have?

ESSA Pharma employs 25 workers across the globe.

What is ESSA Pharma's official website?

The official website for ESSA Pharma is www.essapharma.com.

Where are ESSA Pharma's headquarters?

ESSA Pharma is headquartered at 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5.

How can I contact ESSA Pharma?

ESSA Pharma's mailing address is 999 WEST BROADWAY SUITE 720, VANCOUVER A1, V5Z 1K5. The company can be reached via phone at 778-331-0962, via email at [email protected], or via fax at 604-738-4080.